Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

FHS
June 22, 2024
6:45 am

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).

House passes Biosecure Act, sending Chinese biotech ban to Senate

The US House of Representatives on Monday evening passed the Biosecure Act with broad bipartisan support, advancing a controversial bill that could upend many drugmakers’

September 10, 2024

AstraZeneca completes Gracell Biotechnologies acquisition

Share this article AstraZeneca will gain access to GC012F, a key asset from Gracell. Credit: rarrarorro / Shutterstock.com. AstraZeneca has concluded its acquisition of China-based

February 23, 2024

Fujifilm Diosynth opens new UK facility; Bora completes Emergent factory buy

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Fujifilm Diosynth Biotechnologies has Sign up

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.